The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Array Biopharma competitive analysis

Loading summary...

Latest patents of Array Biopharma opposed by its competitors

Explore Array Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3702351
Nov 22, 2023Formulation Comprising A Mek Inhibitor2
EP3463345
Nov 2, 2022Pharmaceutical Combinations2
EP3400943
Dec 2, 2020Compounds For Use In The Treatment Of Erbb2+ Brain Cancer2
EP3000810
Jul 19, 2017N3 Alkylated Benzimidazole Derivative As Mek Inhibitor1

Latest PTAB cases involving Array Biopharma

Discover the latest PTAB cases involving Array Biopharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Array Biopharma

IPR2015-00754Feb 17, 2015ARRAY BIOPHARMATAKEDA PHARMACEUTICALFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Array Biopharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARRAY BIOPHARMA - 71 -
GENERICS UK TRADING MYLAN13 - - -
SANDOZ1191619 -
STADA ARZNEIMITTEL11028 - -